Convergent Dental, the company behind the Solea All-Tissue Dental Laser, recently announced its participation in the Piper Sandler 36th Annual Healthcare Conference, taking place December 3-5, 2024, at The Lotte New York Palace in New York, NY. This invitation-only event brings together key healthcare executives, investors, and industry experts to explore critical trends and highlight the leaders shaping the future of the healthcare sector.
Rob Gershon, CEO of Convergent Dental, will present on Thursday, December 5, at 8:50 AM EST. Alongside the presentation, Convergent Dental will host one-on-one meetings that same day with investors and industry professionals, offering insights into the company’s latest advancements and its vision for driving the widespread adoption of Solea.
About Convergent Dental
Convergent Dental, Inc. is a privately owned dental equipment and technology company. The Company’s flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists and patients can rely on.1 Solea® enables dentists to elevate their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.2
1. Based on report of 1000 procedures performed by Solea users. Documentation on file.
2. Based on 2022 Annual Survey of Solea users. Documentation on file.
